Evaluation of Dupilumab's Effects on Airway Inflammation in Patients With Asthma

NCT02573233 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

42

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: Placebo
DRUG: Dupilumab SAR231893/REGN668
DRUG: fluticasone propionate and salmeterol
DRUG: budesonide and formoterol
DRUG: mometasone furoate and formoterol

Sponsor

Sanofi

Collaborators

[object Object]